Peptides DB
Research-centric peptide and protocol reference hub
Study 28 of 31Gonadorelin (GnRH) literatureTheriogenology · Observational2026

Prolonged reproductive suppression in domestic cats following a booster dose of an anti-GnRH vaccine.

A booster dose of an anti-GnRH vaccine can extend reproductive suppression in domestic cats for up to 720 days, providing a potential alternative to surgical sterilization.

Read at TheriogenologyAdd to compare

Where it sits

this study against the rest of the gonadorelin (gnrh) corpus
1
Preclinical
28
Observational · this one
0
Open-label
2
Randomised
0
Reviews

Summary and findings

The study evaluated the efficacy and safety of a booster dose of an anti-GnRH vaccine in domestic cats. Twenty-one adult female and seven adult male cats received a primary two-dose series followed by a booster dose at day 300. Reproductive suppression was extended for up to 720 days in some queens, with no pregnancies recorded.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Reproductive suppression was extended for 720 days in ten queens.n=282026

Abstract

The authors’ words, as Theriogenology supplied them

Immunocontraception via anti-GnRH vaccination offers a non-surgical alternative for managing reproduction in domestic cats, but data on the long-term efficacy of booster protocols remain limited. The study aims to evaluate the efficacy and safety of administering a booster dose of an anti-GnRH vaccine Improvac™ 300 days after primary immunization to prolong reproductive suppression in domestic cats. Twenty-one adult female cats and seven adult male cats received a primary two-dose series of the anti-GnRH vaccine 30 days apart, followed by a booster dose at day 300. Animals were monitored for 540 to 720 days post-booster. Assessments included physical and ultrasonographic examinations, reproductive behavior, vaginal cytology, testicular volume, penile spine characteristics, reproductive hormone concentrations, and hematological parameters. All animals respond to the treatment. In male cats, the booster dose accelerated reduction in testosterone, testicular volume, and penile spine size compared with primary immunization alone. Reproductive suppression was extended for 420 days in two queens, 450 days in five queens, 690 days in four queens, and 720 days in ten queens. Serum progesterone remained basal, and no pregnancies were recorded. Some animals (n = 22) showed transient loss of appetite, but hematological parameters remained within reference ranges, and no injection-site inflammation or tenderness was detected. Administering a booster dose 300 days post-primary immunization safely and effectively prolongs immunocontraception in both male and female domestic cats, providing a viable long-term alternative to surgical sterilization.

Background

This paper addresses the efficacy of immunocontraception via anti-GnRH vaccination in domestic cats, an area with limited data on long-term booster protocols. Prior studies have indicated that anti-GnRH vaccines can manage reproduction, but the durability of effects following booster doses was not well understood. This study is significant as it explores the potential of a non-surgical alternative for long-term reproductive management in cats.

Methods

The study utilized a cohort of 28 domestic cats (21 female, 7 male) that received a primary two-dose series of the anti-GnRH vaccine 30 days apart, followed by a booster dose at day 300. Monitoring occurred for 540 to 720 days post-booster, with assessments including physical examinations, reproductive behavior, and hormone concentrations.

Results

The primary endpoint observed was that reproductive suppression lasted up to 720 days in ten queens. All animals responded to the treatment, and in male cats, the booster dose led to an accelerated reduction in testosterone and testicular volume. No pregnancies were recorded, and serum progesterone levels remained basal.

Interpretation

The findings suggest that the booster dose of the anti-GnRH vaccine can significantly prolong reproductive suppression in domestic cats, which aligns with some previous findings on immunocontraception. However, the clinical significance of the extended suppression duration and the small sample size limit the generalizability of these results. Further studies with larger populations and longer follow-up are necessary to confirm these findings.

Key findings

  • Reproductive suppression extended for 420 days in two queens, 450 days in five queens, 690 days in four queens, and 720 days in ten queens.
  • All animals responded to the treatment.
  • In male cats, the booster dose accelerated reduction in testosterone, testicular volume, and penile spine size compared with primary immunization alone.
  • Some animals (n=22) showed transient loss of appetite.
  • Serum progesterone remained basal, and no pregnancies were recorded.

Limitations

  • small sample size of 28 cats
  • follow-up duration may not fully capture long-term effects
  • no control group reported
  • no detailed adverse event reporting

Elsewhere in the Gonadorelin (GnRH) corpus

CGnRH and PGF2α administered at the time of AI differently affect conception rates of non-estrous Nelore cows according to Body Condition Score.Theriogenology · 2026 · n=8061 · GnRH improved fertility in cows with BCS ≥ 2.75 (GnRH: 47%, Control: 38%; P<0.0001).AnimalCSLC32A1 regulates puberty onset in female mice by modulating GnRH neuron function through Kisspeptin and GABA-GABA<sub>B</sub> receptor signaling.Theriogenology · 2026 · Not reported in abstract.AnimalCInfluence of glucocorticoid therapy, Cushing's syndrome and hypothyroidism on the reproductive cycle and AMH levels in the bitch.Theriogenology · 2026 · n=42 · AMH levels of all 21 bitches with changes in their estrous cycle did not differ from those of the bitches without changes (p = 0.47).AnimalCLeuprolide acetate, a GnRH agonist, preserves cerebellar integrity and motor coordination in a rat model of hepatic encephalopathy.Physiology & behavior · 2026 · Not reported in abstract.AnimalDStability and purity profile of gonadorelin acetate: a high-purity gonadotropin-releasing hormone.International journal of fertility · 1990 · Stable for at least 12 months at 24 degrees C in 50% relative humidity.reviewCDeoxynivalenol exposure promotes apoptosis and disrupts GnRH-dependent LH production in pituitary gonadotrope-like cells.Molecular and cellular endocrinology · 2026 · Not reported in abstract.In vitro